CERTIFICATE OF NOTIFICATION

                                       filed by

                                GEORGIA POWER COMPANY


               Pursuant to order of the Securities and Exchange Commission
          dated December 15, 1993, in the matter of File No. 70-8085.

               Georgia Power Company ("GEORGIA") hereby certifies to said
          Commission, pursuant to Rule 24, that, in accordance with the
          terms and conditions of and for the purposes represented by the
          statement on Form U-1, as amended, and of said order with respect
          thereto the following information is provided.

          1.   List of Partnership Portfolio Company/ies.

                                  AtheroGenics, Inc.
                (only one partnership portfolio company at this time)


          2.   Fair Market Value of Partnership's Investment.

                                       $38,750


          3.   General description of the business activities of such
               Partnership Portfolio Company.

               AtheroGenics, Inc. (a Georgia-based company) is engaged in
               the development of novel biopharmaceuticals and diagnostic
               markers which address cardiovascular disease and its
               intervention.

          4.   Aggregate amount invested by GEORGIA in the Partnership
               during such semi-annual period.

                                       $250,000

          5.   GEORGIA's aggregate investment in the Partnership at end of
               June 30, 1994.

                                       $750,000


          Dated:    August 10, 1994               GEORGIA POWER COMPANY


                                                  By:    Wayne Boston      
                                                            Wayne Boston
                                                       Assistant Secretary